Upcoming events on NANOBIOTIX |
|
05/23/22 | 10:45am | | UBS Global Healthcare Conference |
05/24/22 | 11:30am | | Sachs Immuno-Oncology Innovation Forum - Big Pharma Strategy and M&A Panel |
05/24/22 | 01:00pm | | Sachs Immuno-Oncology Innovation Forum - Fireside Chat |
05/25/22 | 08:30am | | H.C. Wainwright Global Life Sciences Investment Conference |
06/03/22 | | American Society for Clinical Oncology Meeting - Abstract No. 18041 |
06/03/22 | | American Society for Clinical Oncology Meeting - Abstract No. TPS6110 |
06/03/22 | | American Society for Clinical Oncology Meeting - Abstract No. 3603 |
06/08/22 | 01:00pm | | Jefferies Healthcare Conference |
06/13/22 | | BIO International Convention |
06/23/22 | | Annual General Meeting |
|
Past events on NANOBIOTIX |
|
05/19/22 | 08:00am | | Q1 2022 Earnings Call |
05/18/22 | 04:40pm | | Q1 2022 Earnings Release |
05/10/22 | | Q1 2022 Sales and Revenue Release |
03/31/22 | 08:00am | | FY 2021 Earnings Call |
03/30/22 | 04:21pm | | FY 2021 Earnings Release |
03/08/22 | | Biomed Event |
02/08/22 | | European MidCap Event®Frankfurt |
01/17/22 | | Biotech Showcase |
01/10/22 | | H.C. Wainwright BioConnect Conference |
01/06/22 | | ODDO BHF Forum |
|
Past dividends on NANOBIOTIX |
|
- No events available -
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M € |
Released Forecast Spread | 3,72 7,50 -50% | 3,48 4,37 -20% | 2,54 3,75 -32% | 2,51 2,19 15% | 2,65 16,7 -84% | 1,25 |
Operating income (EBITDA) M € |
Released Forecast Spread | -24,9 -21,9 -13% | -29,4 -27,0 -9,2% | -45,0 -43,3 -4,1% | -34,7 -41,5 16% | -51,0 -72,0 29% | -50,4 |
Operating profit (EBIT) M € |
Released Forecast Spread | -25,3 -22,4 -13% | -30,1 -27,1 -11% | -46,8 -43,9 -6,6% | -36,4 -38,8 6,0% | -52,6 -73,4 28% | -51,5 |
Pre-Tax Profit (EBT) M € |
Released Forecast Spread | -26,1 -23,3 -12% | -30,3 -29,1 -4,2% | -50,9 -44,6 -14% | -33,6 -44,1 24% | -47,0 -118 60% | -167 |
Net income M € |
Released Forecast Spread | -26,1 -19,7 -33% | -30,3 -29,1 -4,3% | -50,9 -45,9 -11% | -33,6 -38,5 13% | -47,0 -74,2 37% | -52,1 |
EPS € |
Released Forecast Spread | -1,50 -1,14 -32% | -1,55 -1,33 -17% | -2,35 -2,11 -11% | -1,40 -1,28 -9,3% | -1,35 -1,47 8,2% | -1,50 | Announcement Date | 03/30/2018 | 03/15/2019 | 03/17/2020 | 03/17/2021 | 03/30/2022 | - |
|
|
Fiscal Period : December | 2017 S2 | 2018 S1 | 2018 S2 | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 |
Sales M € |
Released Forecast Spread | 1,84 3,00 -39% |
| 1,42 2,16 -34% | 1,82 1,70 7,6% | 0,72 1,95 -63% | 1,45 2,00 -28% | 1,06 1,90 -44% | 1,32 0,90 47% |
|
|
|
|
Operating profit (EBIT) M € |
Released Forecast Spread | -13,5 -11,7 -15% |
| -17,1 -12,9 -32% | -20,5 -18,6 -10% | -26,3 -20,1 -31% | -18,4 -24,2 24% | -18,0 -21,7 17% | -29,8 -19,1 -56% |
|
| -36,0 | -46,0 |
Pre-Tax Profit (EBT) M € |
Released Forecast Spread | -14,0 -11,8 -18% |
|
| -23,9 -18,0 -33% | -27,0 -20,7 -31% | -20,6 -25,6 20% | -13,0 -23,3 44% | -30,4 -20,3 -50% |
|
| -36,4 | -46,4 |
Net income M € |
Released Forecast Spread | -14,0 -11,8 -18% | -12,6 -16,0 21% |
| -23,9 -18,0 -33% | -27,0 -20,7 -31% | -20,6 -25,6 20% | -13,0 -23,3 44% | -30,4 -20,3 -50% | -14,4 | -20,4 | -36,4 | -46,4 |
EPS
|
Released Forecast Spread | -0,74 -0,70 -5,7% |
| -0,91
| -1,15 -0,90 -28% | -1,20 -0,94 -28% | -0,91 -1,10 17% | -0,49 -0,70 30% | -0,88 -0,60 -47% |
|
|
|
| Announcement Date | 03/30/2018 | 09/04/2018 | 03/15/2019 | 09/04/2019 | 03/17/2020 | 09/04/2020 | 03/17/2021 | 09/08/2021 | 06/08/2021 | 09/08/2021 | 12/30/2021 | 03/30/2022 | |
|
|
Upcoming sector events for NANOBIOTIX |
|
|
|
Past sector events for NANOBIOTIX |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|